• Explore /
  • Poster
  • / Immunotherapy (IT) with ch14.18/CHO for high-risk neuroblastoma: First results from the randomised HR-NBL1/SIOPEN trial.

Immunotherapy (IT) with ch14.18/CHO for high-risk neuroblastoma: First results from the randomised HR-NBL1/SIOPEN trial.

Abstract Poster

Authors

Ruth Ladenstein

Ruth L Ladenstein

St. Anna Children's Cancer Research Institute, Vienna, Austria

Ruth L Ladenstein , Ulrike Poetschger , Roberto Luksch , Penelope Brock , Victoria Castel , Isaac Yaniv , Vassilios Papadakis , Genevieve Laureys , Josef Malis , Walentyna Balwierz , Ellen Ruud , Per Kogner , Henrik Schroeder , Maja Beck Popovic , Peter F Ambros , Guenter Schreier , Holger N. Lode , Hans Loibner , Andrew DJ Pearson , Dominique Valteau Couanet

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Pediatric Solid Tumors

Clinical Trial Registration Number

NCT01704716

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 10026)

DOI

10.1200/jco.2014.32.15_suppl.10026

Abstract #

10026

Poster Bd #

327

Abstract Disclosures

Similar Posters

First Author: Keith Holmes

First Author: Leonard Joseph Appleman

First Author: Meaghan Granger

First Author: Ruth Ladenstein